MedTrace Logo

High-Intensity Interval Training Effects on Fitness in Youth Soccer Players

NCT07757100 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-08-11

No results posted yet for this study

Summary

This study aims to investigate the effects of an 8-week high-intensity interval training (HIIT) program on aerobic capacity, anaerobic power, blood lactate levels, and sprint performance in young male soccer players. Twenty-four volunteer U19-category soccer players from Sivasspor A.Ş. were randomly allocated into an experimental group (n=12), which performed HIIT three days per week for 8 weeks in addition to their regular training, and a control group (n=12), which continued only their routine training program. Anthropometric measurements, resting heart rate, aerobic performance (Yo-Yo IRT1), anaerobic performance (RAST), and blood lactate levels were assessed before and after the intervention period.

Conditions

  • Athletic Performance

Interventions

BEHAVIORAL

High-Intensity Interval Training (HIIT)

Participants in the HIIT group performed high-intensity interval training three times per week for 8 weeks, in addition to their regular soccer training. Each session consisted of repeated high-intensity running intervals designed to improve aerobic capacity, anaerobic power, and sprint performance.

Sponsors & Collaborators

  • Ercüment Erdoğan

    lead OTHER

Principal Investigators

  • Ercüment Erdoğan, PhD · Ordu University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-20
Primary Completion
2021-11-14
Completion
2021-11-16

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07757100 on ClinicalTrials.gov